Hot off the ADA 2023 press.
Dr. Sunni (Cheng Yi) Yuan presents late breaking work at ADA 2023
We are very proud to announce that Dr Sunni Yuan, former D.T.R.G research fellow, presented work from our Sensor Line Combo Study at the American Diabetes Association’s 2023 Scientific Sessions, which are underway in sunny San Diego, California, USA.
Featured on multiple news websites, this presentation on Feasibility of a Prototype Dual Function Glucose Sensing Insulin Delivery Cannula in People with Type 1 Diabetes is a great step forward for quality of life when it comes to those living with diabetes.
Presented as both a poster and an oral presentation; the project involved the use of an artificial pancreas, the first device of it’s kind featuring both through the skin glucose monitoring and insulin delivery; resulting in the proven efficacy of Pacific Diabetes Technologies SynerG System.
“We believe these findings represent a potentially significant step forward in the management of glucose levels for those living with diabetes with the feasibility of a single insertion subcutaneous device able to both sense glucose and infuse insulin. We envision a device like this will help to minimize the burden of care and associated psychological distress for those living with diabetes who require insulin,”
– Professor David O’Neal
Hot off the ADA 2023 press.
Dr. Sunni (Cheng Yi) Yuan presents late breaking work at ADA 2023
We are very proud to announce that Dr Sunni Yuan, former D.T.R.G research fellow, presented work from our Sensor Line Combo Study at the American Diabetes Association’s 2023 Scientific Sessions, which are underway in sunny San Diego, California, USA.
Featured on multiple news websites, this presentation on Feasibility of a Prototype Dual Function Glucose Sensing Insulin Delivery Cannula in People with Type 1 Diabetes is a great step forward for quality of life when it comes to those living with diabetes.
Presented as both a poster and an oral presentation; the project involved the use of an artificial pancreas, the first device of it’s kind featuring both through the skin glucose monitoring and insulin delivery; resulting in the proven efficacy of Pacific Diabetes Technologies SynerG System.
“We believe these findings represent a potentially significant step forward in the management of glucose levels for those living with diabetes with the feasibility of a single insertion subcutaneous device able to both sense glucose and infuse insulin. We envision a device like this will help to minimize the burden of care and associated psychological distress for those living with diabetes who require insulin,”
– Professor David O’Neal